{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:13:13Z","timestamp":1790111593244,"version":"4.0.1"},"reference-count":15,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.3201\/eid3210.260186","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:58:19Z","timestamp":1790110699000},"source":"Crossref","is-referenced-by-count":0,"title":["Comparison of Baloxavir-Based Combinations and Monotherapies for Treating Influenza A(H5N1) Clade 2.3.4.4b Virus Infection in Mice"],"prefix":"10.3201","volume":"32","author":[{"given":"Seong Cheol","family":"Min","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Ryeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom Kyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Gyu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gi Chan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Hee","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Chokkakula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aman","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Ki","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Hee","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Suk","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid3210.260186-202609221658-R1","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1093\/infdis\/jiae379","article-title":"An update on highly pathogenic avian influenza A(H5N1) virus, clade 2.3.4.4b.","volume":"230","author":"Webby","year":"2024","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid3210.260186-202609221658-R2","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.3201\/eid2912.230464","article-title":"Highly pathogenic avian influenza A(H5N1) virus clade 2.3.4.4b infections in wild terrestrial mammals, United States, 2022.","volume":"29","author":"Elsmo","year":"2023","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid3210.260186-202609221658-R3","doi-asserted-by":"publisher","first-page":"2300001","DOI":"10.2807\/1560-7917.ES.2023.28.3.2300001","article-title":"Highly pathogenic avian influenza A(H5N1) virus infection in farmed minks, Spain, October 2022.","volume":"28","author":"Ag\u00fcero","year":"2023","journal-title":"Euro Surveill"},{"key":"key-10.3201\/eid3210.260186-202609221658-R4","doi-asserted-by":"publisher","first-page":"101240","DOI":"10.1016\/j.lanmic.2025.101240","article-title":"A pandemic toolbox for clade 2.3.4.4b A(H5N1) influenza virus risk assessment.","volume":"7","author":"Belser","year":"2026","journal-title":"Lancet Microbe"},{"key":"key-10.3201\/eid3210.260186-202609221658-R5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.antiviral.2013.03.014","article-title":"Influenza virus resistance to neuraminidase inhibitors.","volume":"98","author":"Samson","year":"2013","journal-title":"Antiviral Res"},{"key":"key-10.3201\/eid3210.260186-202609221658-R6","doi-asserted-by":"publisher","first-page":"9633","DOI":"10.1038\/s41598-018-27890-4","article-title":"Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil.","volume":"8","author":"Omoto","year":"2018","journal-title":"Sci Rep"},{"key":"key-10.3201\/eid3210.260186-202609221658-R7","first-page":"337","article-title":"Baloxavir and treatment-emergent resistance: public health insights and next steps.","volume":"221","author":"Gubareva","year":"2020","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid3210.260186-202609221658-R8","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/s41564-025-01961-5","article-title":"Baloxavir improves disease outcomes in mice after intranasal or ocular infection with influenza A virus H5N1-contaminated cow\u2019s milk.","volume":"10","author":"Jones","year":"2025","journal-title":"Nat Microbiol"},{"key":"key-10.3201\/eid3210.260186-202609221658-R9","doi-asserted-by":"publisher","first-page":"2601372","DOI":"10.1080\/22221751.2025.2601372","article-title":"Antiviral susceptibility of clade 2.3.4.4b highly pathogenic avian influenza A(H5N1) viruses from humans in the United States, October 2024 to February 2025.","volume":"15","author":"Pascua","year":"2026","journal-title":"Emerg Microbes Infect"},{"key":"key-10.3201\/eid3210.260186-202609221658-R10","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/s41586-024-08254-7","article-title":"A human isolate of bovine H5N1 is transmissible and lethal in animal models.","volume":"636","author":"Gu","year":"2024","journal-title":"Nature"},{"key":"key-10.3201\/eid3210.260186-202609221658-R11","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1038\/s41467-026-69721-5","article-title":"Baloxavir outperforms oseltamivir, favipiravir, and amantadine in treating lethal influenza A(H5N1) HA clade 2.3.4.4b infection in mice.","volume":"17","author":"Andreev","year":"2026","journal-title":"Nat Commun"},{"key":"key-10.3201\/eid3210.260186-202609221658-R12","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1744-7348.1939.tb06990.x","article-title":"The toxicity of poisons applied jointly.","volume":"26","author":"Bliss","year":"1939","journal-title":"Ann Appl Biol"},{"key":"key-10.3201\/eid3210.260186-202609221658-R13","unstructured":"US Food and Drug Administration. Fact sheet for healthcare providers: Emergency Use Authorization for Lagevrio\u2122 (molnupiravir) capsules. Revised 2024 Jun [cited 2026 Jan 25]. https:\/\/www.fda.gov"},{"key":"key-10.3201\/eid3210.260186-202609221658-R14","doi-asserted-by":"publisher","first-page":"2645843","DOI":"10.1080\/22221751.2026.2645843","article-title":"Antiviral activities of multiple antivirals against highly pathogenic avian influenza A H5N1 in vitro and in mice.","volume":"15","author":"Liu","year":"2026","journal-title":"Emerg Microbes Infect"},{"key":"key-10.3201\/eid3210.260186-202609221658-R15","doi-asserted-by":"publisher","first-page":"110642","DOI":"10.1016\/j.virol.2025.110642","article-title":"The combinatorial activities of oseltamivir and molnupiravir against influenza virus infections in vitro and in vivo.","volume":"611","author":"Feng","year":"2025","journal-title":"Virology"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:58:20Z","timestamp":1790110700000},"score":1,"resource":{"primary":{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/32\/10\/26-0186_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"URL":"https:\/\/doi.org\/10.3201\/eid3210.260186","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]}}}